References
1. Risberg S, Engfeldt P, Hugosson S. Incidence of peritonsillar abscess and relationship to age and gender: retrospective study. Scand J Infect Dis. 2008;40(10):792–6.
2. Galioto NJ. Peritonsillar Abscess. AFP. 2008 Jan 15;77(2):199–202.
3. Johnson MM. 7 - Ear, Nose, and Throat Infections. In: Kradin RL, editor. Diagnostic Pathology of Infectious Disease (Second Edition) [Internet]. Elsevier; 2018 [cited 2022 Feb 12]. p. 120. Available from: https://www.sciencedirect.com/science/article/pii/B9780323445856000072
4. Chang BA, Thamboo A, Burton MJ, Diamond C, Nunez DA. Needle aspiration versus incision and drainage for the treatment of peritonsillar abscess. Cochrane Database of Systematic Reviews [Internet]. 2016 [cited 2021 Dec 6];(12). Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006287.pub4/full
5. Klug TE. Peritonsillar abscess: clinical aspects of microbiology, risk factors, and the association with parapharyngeal abscess. Dan Med J. 2017 Mar;64(3):B5333.
6. Inman JC, Rowe M, Ghostine M, Fleck T. Pediatric neck abscesses: changing organisms and empiric therapies. Laryngoscope. 2008 Dec;118(12):2111–4.
7. Ehlers Klug T, Rusan M, Fuursted K, Ovesen T. Fusobacterium necrophorum: most prevalent pathogen in peritonsillar abscess in Denmark. Clin Infect Dis. 2009 Nov 15;49(10):1467–72.
8. Ryan S, Papanikolaou V, Keogh I. Appraisal of the peri-hospital management and evolving microbiology of peritonsillar abscess disease. B-ENT. 2014;10(1):15–20.
9. Visvanathan V, Nix P. National UK survey of antibiotics prescribed for acute tonsillitis and peritonsillar abscess. J Laryngol Otol. 2010 Apr;124(4):420–3.
10. Al Yaghchi C, Cruise A, Kapoor K, Singh A, Harcourt J. Out-patient management of patients with a peritonsillar abscess. Clin Otolaryngol. 2008 Feb;33(1):52–5.
11. Mazur E, Czerwińska E, Korona-Głowniak I, Grochowalska A, Kozioł-Montewka M. Epidemiology, clinical history and microbiology of peritonsillar abscess. Eur J Clin Microbiol Infect Dis. 2015 Mar;34(3):549–54.
12. Scott-Brown WG, Gleeson M. Scott-Brown’s otolaryngology, head and neck surgery. London: Hodder Arnold; 2008.
13. Ramirez S, Hild TG, Rudolph CN, Sty JR, Kehl SC, Havens P, et al. Increased diagnosis of Lemierre syndrome and other Fusobacterium necrophorum infections at a Children’s Hospital. Pediatrics. 2003 Nov;112(5):e380.
14. Lemierre A. On Certain Septicaemias Due To Anaerobic Organisms. The Lancet. 1936 Mar 28;227(5874):701–3.
15. Wikstén JE, Pitkäranta A, Blomgren K. Metronidazole in conjunction with penicillin neither prevents recurrence nor enhances recovery from peritonsillar abscess when compared with penicillin alone: a prospective, double-blind, randomized, placebo-controlled trial. Journal of Antimicrobial Chemotherapy. 2016 Jun 1;71(6):1681–7.
16. Kieff DA, Bhattacharyya N, Siegel NS, Salman SD. Selection of Antibiotics after Incision and Drainage of Peritonsillar Abscesses. Otolaryngol Head Neck Surg. 1999 Jan 1;120(1):57–61.
17. Wiens J, Snyder GM, Finlayson S, Mahoney MV, Celi LA. Potential Adverse Effects of Broad-Spectrum Antimicrobial Exposure in the Intensive Care Unit. Open Forum Infectious Diseases. 2018 Feb 1;5(2):ofx270.
18. Fair RJ, Tor Y. Antibiotics and Bacterial Resistance in the 21st Century. Perspect Medicin Chem. 2014 Aug 28;6:25–64.
19. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71.
20. Tunér K, Nord CE. Impact on peritonsillar infections and microflora of phenoxymethylpenicillin alone versus phenoxymethylpenicillin in combination with metronidazole. Infection. 1986 Jun;14(3):129–33.
21. Yilmaz T, Unal OF, Figen G, Akyol MU, Ayas K. A comparison of procaine penicillin with sulbactam-ampicillin in the treatment of peritonsillar abscesses. Eur Arch Otorhinolaryngol. 1998;255(3):163–5.
22. Wexler HM, Molitoris E, Finegold SM. Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria. Antimicrob Agents Chemother. 1991 Jun;35(6):1219–24.
23. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Aug 28;366:l4898.
24. Wells G, Shea B, O’Connel D, Peterson J, Welch V, Losos M. Ottawa Hospital Research Institute [Internet]. [cited 2021 Dec 20]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
25. Mehanna HM, Al-Bahnasawi L, White A. National audit of the management of peritonsillar abscess. Postgraduate Medical Journal. 2002 Sep 1;78(923):545–7.
26. Smith A. Metronidazole resistance: a hidden epidemic? Br Dent J. 2018 Mar;224(6):403–4.
27. Snow DG, Campbell JB, Morgan DW. The microbiology of peritonsillar sepsis. J Laryngol Otol. 1991 Jul;105(7):553–5.
28. Excellence NTNI for H and C. BNF: British National Formulary - NICE [Internet]. NICE; [cited 2021 Dec 20]. Available from: https://bnf.nice.org.uk/medicinal-forms/metronidazole.html
29. Hardingham M. Peritonsillar infections. Otolaryngol Clin North Am. 1987 May;20(2):273–8.